biotech

Whether they prefer long-term investing or short-term trading, investors should find the strategy that works best for them.

Emotional investing carries a significant risk – and few companies can live up to the expectations it sets.

Marc’s bold biotech prediction pans out. Will it continue to hold true in 2020?

Biotech stocks can be potent choices for investors, but it’s important to be a good judge of their potential.

This biopharma giant may be garnering negative press lately, but its dividend safety tells a different story.

In a bear market, investors should suit their strategy to their time frame.

New advances in treating common conditions aren’t great news just for those afflicted – they’re also great news for biotech investors.

Remaining objective while investing isn’t just responsible… it’s necessary.

Though biotech used to have a reputation for being volatile, it can actually help defend your portfolio against a recession.

It might be tempting to buy an IPO of a biotech company. But should you?